Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Brand Ambassadors

A brief introduction of Bentham Science Brand Ambassador:

Bentham Science Ambassador Program, a project of Bentham Science, is an effort to liaison between the researcher and the publisher. This program will act as a tool to spread information and knowledge about Bentham content and initiatives among the research community. Through promoting Bentham Science content, the Bentham Science Ambassador encourages researchers to contribute to Bentham Science publications, and will in return be rewarded points for the tasks performed by them, which they could redeem through various offers & incentives by Bentham Science such as, Bentham Science eBooks, Open Access Journal, etc. This online portal will facilitate the ambassadors in performing their tasks.

Become Bentham Brand Ambassador

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog